Home » Stocks » INSP

Inspire Medical Systems, Inc. (INSP)

Stock Price: $220.81 USD 1.21 (0.55%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 5.95B
Revenue (ttm) 96.28M
Net Income (ttm) -58.80M
Shares Out 26.84M
EPS (ttm) -2.32
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $220.81
Previous Close $219.60
Change ($) 1.21
Change (%) 0.55%
Day's Open 217.70
Day's Range 216.56 - 222.93
Day's Volume 190,178
52-Week Range 41.62 - 223.53

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 3 days ago

MINNEAPOLIS, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

GlobeNewsWire - 4 days ago

MINNEAPOLIS, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

Investors Business Daily - 1 week ago

Small-caps Outperform As Breakouts Continue; Inspire Medical, Qualcomm, And Yatsen In Focus

Small-caps take their turn to shine as breakouts continue in Inspire Medical, Qualcomm, and Yatsen. Investor's Business Daily has been helping people invest smarter results by providing exclus...

Other stocks mentioned: QCOM, YSG
Forbes - 3 weeks ago

The indices are now remarkably up since the start of the year after where they were in March. The Nasdaq has soared over 43% year to date led by “stay-at-home” high flying tech names.

Other stocks mentioned: MAXR, RDFN, WORK, Z, ZG
GlobeNewsWire - 1 month ago

MINNEAPOLIS, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

Forbes - 1 month ago

During its debut, Tesla fell more than 4%. Meanwhile, the E.U.

Other stocks mentioned: LPSN, SPCE, TENB, WTER
Forbes - 1 month ago

Although major indices ended last week at record highs despite a disappointing November jobs report, the Dow and S&P came back down to earth today and slipped. The deep learning algorithms at ...

Other stocks mentioned: CVNA, HASI, PLUG
Forbes - 1 month ago

As COVID surges to unprecedented levels with additional shutdown measures taking place, markets dropped after yesterday's surge. Using our deep learning algorithms, our AI has crunched the dat...

Other stocks mentioned: CVNA, HASI, PING, Z, ZG
GlobeNewsWire - 2 months ago

MINNEAPOLIS, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

GlobeNewsWire - 2 months ago

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

Seeking Alpha - 2 months ago

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Inspire (INSP) delivered earnings and revenue surprises of 45.07% and 59.33%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 2 months ago

Shares of Inspire Medical Systems (NYSE:INSP) rose 9.53% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were down 14.71% over the past year...

GlobeNewsWire - 2 months ago

MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovati...

Zacks Investment Research - 2 months ago

Several medical product stocks have come up with bullish earnings reports so far this reporting cycle. Let's see how STE, HSIC, PACB, INSP are poised ahead of their announcements.

Other stocks mentioned: HSIC, PACB, STE
GlobeNewsWire - 2 months ago

MINNEAPOLIS, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovati...

Zacks Investment Research - 2 months ago

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 3 months ago

MINNEAPOLIS, Sept. 24, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 4 months ago

MINNEAPOLIS, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 4 months ago

MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 5 months ago

MINNEAPOLIS, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 5 months ago

MINNEAPOLIS, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innova...

Seeking Alpha - 5 months ago

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Inspire (INSP) delivered earnings and revenue surprises of 18.52% and 39.71%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Benzinga - 5 months ago

Shares of Inspire Medical Systems (NYSE:INSP) were flat in after-market trading after the company reported Q2 results.

GlobeNewsWire - 5 months ago

MINNEAPOLIS, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innova...

Zacks Investment Research - 5 months ago

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 6 months ago

MINNEAPOLIS, July 09, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 7 months ago

MINNEAPOLIS, June 16, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 7 months ago

MINNEAPOLIS, June 08, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 7 months ago

MINNEAPOLIS, June 03, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 8 months ago

MINNEAPOLIS, May 11, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovat...

Seeking Alpha - 8 months ago

Inspire Medical Systems' (INSP) CEO Tim Herbert on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Inspire (INSP) delivered earnings and revenue surprises of -17.54% and 0.03%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 8 months ago

Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 9 months ago

MINNEAPOLIS, April 21, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, April 16, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:  INSP) (“Inspire”), a medical technology company focused on the development and commercialization of inno...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, April 13, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, April 13, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innov...

GlobeNewsWire - 9 months ago

MINNEAPOLIS, April 13, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innov...

Zacks Investment Research - 9 months ago

Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Investors Business Daily - 10 months ago

Strong Start Fades As Stock Market Correction Continues

Stocks pared back gains as weakness continued; Lessons from Disney, Inspire Medical and TJX.

Other stocks mentioned: DIS, TJX
Seeking Alpha - 10 months ago

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q4 2019 Results - Earnings Call Transcript

Zacks Investment Research - 10 months ago

Inspire (INSP) delivered earnings and revenue surprises of 9.52% and 12.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 10 months ago

Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

InvestorPlace - 11 months ago

While the large caps get all the attention, lately, this is more of a negative development than a positive one

Other stocks mentioned: ATRO, BGS, ESTC, FRPT, NOG, PETS, WLBMF
GlobeNewsWire - 11 months ago

MINNEAPOLIS, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innova...

GlobeNewsWire - 1 year ago

MINNEAPOLIS, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovati...

Seeking Alpha - 1 year ago

Inspire Medical: The Momentum Continues To Build

About INSP

Inspire Medical Systems, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was founded in 2007 and... [Read more...]

Industry
Medical Devices
IPO Date
May 3, 2018
CEO
Timothy Herbert
Employees
239
Stock Exchange
NYSE
Ticker Symbol
INSP
Full Company Profile

Financial Performance

In 2019, INSP's revenue was $82.05 million, an increase of 62.18% compared to the previous year's $50.59 million. Losses were -$33.24 million, 52.3% more than in 2018.

Financial Statements

Analyst Forecasts

According to 13 analysts, the average rating for INSP stock is "Buy." The 12-month stock price forecast is 194.92, which is a decrease of -11.73% from the latest price.

Price Target
$194.92
(-11.73% downside)
Analyst Consensus: Buy